Arcturus Therapeutics Holdings Inc (NQ: ARCT )
26.88 UNCHANGED Streaming Delayed Price Updated: 4:00 PM EDT, Jun 2, 2023 Add to My Watchlist
Headline News about Arcturus Therapeutics Holdings Inc
Benzinga's Top Ratings Upgrades, Downgrades For November 2, 2022
November 02, 2022
BARDA Backs Arcturus' Influenza Vaccine Program
September 01, 2022
Benzinga's Top Ratings Upgrades, Downgrades For August 10, 2022
August 10, 2022
Arcturus Therapeutics Holdings Inc (NASDAQ: ARCT) provided updated data from its Phase 1/2 booster clinical trial showing the durability of antibody response with ARCT-154 for at least three months...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following